The Effect of Ivabradine on the Human Atrial Myocardial Contractility in an In Vitro Study
Purpose. Ivabradine has emerged as a new antiarrhythmic agent that could compete with the traditional ones, such as beta-blockers. This experimental study aims to ascertain whether ivabradine directly interferes with the myocardial contractility in an in vitro environment. Methods. Myocardial tissue...
Saved in:
Main Authors: | Ryan Chaban, Katja Buschmann, Anna Krausgrill, Andres Beiras-Fernandez, Christian-Friedrich Vahl |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Cardiology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2019/7512318 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of Ivabradine on Residual Myocardial Ischemia after PCI Evaluated by Stress Echocardiography
by: Simone Calcagno, et al.
Published: (2019-01-01) -
MicroRNA-221 protects myocardial contractility in myocardial ischemia/reperfusion injury through phospholamban.
by: Hongyu Li, et al.
Published: (2025-01-01) -
Adjuvant Use of Ivabradine in Acute Heart Failure due to Myocarditis
by: Jennifer Franke, et al.
Published: (2011-01-01) -
Human Bone Marrow Contains Mesenchymal Stromal Stem Cells That Differentiate In Vitro into Contractile Myofibroblasts Controlling T Lymphocyte Proliferation
by: Yves Lecarpentier, et al.
Published: (2018-01-01) -
Cellular Contractility Profiles of Human Diabetic Corneal Stromal Cells
by: Thi N. Lam, et al.
Published: (2021-01-01)